Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Invo Bioscience Inc
(NQ:
INVO
)
0.8330
UNCHANGED
Last Price
Updated: 3:55 PM EDT, Oct 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Invo Bioscience Inc
< Previous
1
2
3
4
5
6
7
Next >
Why Is Surgalign Holdings (SRGA) Stock Down 23% Today?
June 26, 2023
Surgalign Holdings (SRGA) stock is taking a beating on Monday after the company revealed a delisting notice from the Nasdaq Exchange.
Via
InvestorPlace
Why Is iMedia Brands (IMBI) Stock Up 36% Today?
June 26, 2023
IMedia Brands (IMBI) stock is rising on Monday morning despite the company receiving another delisting notice from the Nasdaq Exchange.
Via
InvestorPlace
Why Lucid Group Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
June 26, 2023
Gainers TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares surged 84.1% to $15.54 in pre-market trading after jumping over 15% on Friday. Superlatus, Inc. signed a binding letter of intent to be acquired by...
Via
Benzinga
Why Is INVO Bioscience (INVO) Stock Up 82% Today
June 26, 2023
INVO Bioscience (INVO) stock is on the rise Monday after the company announced a public share offering on Friday morning.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 26, 2023
It's time to start off the week right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
INVO Bioscience's Return On Capital Employed Overview
April 18, 2023
Via
Benzinga
INVO Bioscience's Earnings: A Preview
April 14, 2023
Via
Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 16, 2023
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
June 14, 2023
On Wednesday, 33 stocks hit new 52-week lows.
Via
Benzinga
Recap: INVO Bioscience Q2 Earnings
August 15, 2022
INVO Bioscience (NASDAQ:INVO) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 31, 2023
Via
Benzinga
Earnings Scheduled For April 17, 2023
April 17, 2023
Companies Reporting Before The Bell • Charles Schwab (NYSE:SCHW) is expected to report quarterly earnings at $0.90 per share on revenue of $5.15 billion.
Via
Benzinga
Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
March 23, 2023
Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) shares rose 82.8% to $2.98 in pre-market trading. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule...
Via
Benzinga
Why Is INVO Bioscience Stock Trading Higher Today?
March 20, 2023
INVO Bioscience (NASDAQ: INVO) shares are trading higher on Monday after the company announced it signed binding agreements to acquire Wisconsin Fertility Institute.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 15, 2022
Via
Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 25, 2023
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 13, 2022
Via
Benzinga
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket
December 12, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 12, 2022
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
INVO Bioscience's Return On Capital Employed Insights
September 12, 2022
INVO Bioscience (NASDAQ:INVO) brought in sales totaling $146 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 0.98%, resulting in a loss of $2.80 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 16, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.